Kato K - Search Results

1

Elevated serum soluble Fas ligand in natural killer cell proliferative disorders.

Kato K, Ohshima K, Ishihara S, Anzai K, Suzumiya J, Kikuchi M. Kato K, et al. Br J Haematol. 1998 Dec;103(4):1164-6. doi: 10.1046/j.1365-2141.1998.01095.x. Br J Haematol. 1998. PMID: 9886336 Free article.

2

Elevated serum-soluble Fas ligand in histiocytic necrotizing lymphadenitis.

Kato K, Ohshima K, Anzai K, Suzumiya J, Kikuchi M. Kato K, et al. Int J Hematol. 2001 Jan;73(1):84-6. doi: 10.1007/BF02981907. Int J Hematol. 2001. PMID: 11372760

3

Rearrangement of immunoglobulin heavy and light chains and VH family in thyroid and salivary gland lymphomas.

Kato K, Ohshima K, Shiokawa S, Shibata T, Suzumiya J, Kikuchi M. Kato K, et al. Pathol Int. 2002 Dec;52(12):747-54. doi: 10.1046/j.1440-1827.2002.01418.x. Pathol Int. 2002. PMID: 12588443

4

Modified CHOP in an aged patient with non-Hodgkin's lymphoma and probable extensive pulmonary involvement.

Asano Y, Ohshima K, Yoshizawa S, Shiraishi G, Kato K. Asano Y, et al. Among authors: kato k. Int J Hematol. 1991 Aug;54(4):327-9. Int J Hematol. 1991. PMID: 1777606

5

Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function.

Shimoda K, Kato K, Aoki K, Matsuda T, Miyamoto A, Shibamori M, Yamashita M, Numata A, Takase K, Kobayashi S, Shibata S, Asano Y, Gondo H, Sekiguchi K, Nakayama K, Nakayama T, Okamura T, Okamura S, Niho Y, Nakayama K. Shimoda K, et al. Among authors: kato k. Immunity. 2000 Oct;13(4):561-71. doi: 10.1016/s1074-7613(00)00055-8. Immunity. 2000. PMID: 11070174 Free article.

6

Beneficial treatment with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in a patient with primary myelofibrosis.

Asano Y, Shimokawa M, Okabe H, Sanefuji H, Kato K. Asano Y, et al. Among authors: kato k. Acta Haematol. 1991;85(2):103-4. doi: 10.1159/000204866. Acta Haematol. 1991. PMID: 2024552

7

Deep Learning Models for Histopathological Classification of Gastric and Colonic Epithelial Tumours.

Iizuka O, Kanavati F, Kato K, Rambeau M, Arihiro K, Tsuneki M. Iizuka O, et al. Among authors: kato k. Sci Rep. 2020 Jan 30;10(1):1504. doi: 10.1038/s41598-020-58467-9. Sci Rep. 2020. PMID: 32001752 Free PMC article.

8

Relationship Between Short-Term Outcomes and PD-L1 Expression Based on Combined Positive Score and Tumor Proportion Score in Recurrent or Metastatic Head and Neck Cancers Treated With Anti-PD-1 Antibody Monotherapy.

Ohara A, Mori T, Itoyama M, Yokoyama K, Yamamoto S, Kato K, Honma Y. Ohara A, et al. Among authors: kato k. Cancer Rep (Hoboken). 2025 Jan;8(1):e70125. doi: 10.1002/cnr2.70125. Cancer Rep (Hoboken). 2025. PMID: 39840665

9

Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55.

Oshima S, Arai Y, Kondo T, Yano S, Hirabayashi S, Uchida N, Onizuka M, Miyakoshi S, Tanaka M, Takahashi S, Hayashi M, Kawakita T, Uehara Y, Ota S, Izumi T, Sawa M, Nishida T, Katayama Y, Nagafuji K, Kato K, Ichinohe T, Atsuta Y, Yanada M. Oshima S, et al. Among authors: kato k. Bone Marrow Transplant. 2025 Jan 21. doi: 10.1038/s41409-025-02508-2. Online ahead of print. Bone Marrow Transplant. 2025. PMID: 39838078

10

Non-invasive electron paramagnetic resonance imaging detects tumor redox imbalance induced by ferroptosis.

Kato K, Yasui H, Sato-Akaba H, Emoto MC, Fujii HG, Kmiec MM, Kuppusamy P, Nagane M, Yamashita T, Inanami O. Kato K, et al. Redox Rep. 2025 Dec;30(1):2454887. doi: 10.1080/13510002.2025.2454887. Epub 2025 Jan 21. Redox Rep. 2025. PMID: 39836064 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,953 results

Search Page

Filters